Abstract
It is a perennial plant that grows naturally in the central and southern areas of Europe. Dioscorides described two types: one called Roman that grows in damp, cold and snowy mountains; the second type also grows in damp places, but its roots are less bitter and weaker in properties than the first one. Gentian is anthelmintic, antiseptic, emmenagogue, febrifuge, stimulant, stomachic, and tonic, and is used to stimulate gastric secretion, improve appetite and digestion and alleviate debility; also, for blood disorders, cancer, cold, convulsions, diarrhea, dog-bite, dysmenorrhea, dyspepsia, gastritis, gout, jaundice, malaria, oliguria, snakebite, splenitis, stomachache, syncope and wounds. In the central and southern Europe, gentian extract is used in nonalcoholic beverages, frozen dairy desserts, candy, baked goods, gelatins and puddings; and in some antismoking compounds and cosmetics. In Montenegro, leaves are traditionally utilized as hepatoprotective, hypoglycemic and anti-inflammatory agents. G. lutea is approved for GI disorders use in Europe since Sep. 2007 by the HMPC of the European Medicines Agency. The roots contain glucosides: gentiopicrine; also, gentiamarine, amarogentine, the glycoside gentiin; the tannin like principle gentiamarin, gentisin, gentisic acid and the trisaccharide gentianose, triterpinoids, iridoids, secoiridoids, xanthones, xanthone glycosides, and MAO-B inhibitors. Amarogentin is one of the most bitter natural compounds and is used to measure comparative bitterness. In a crossover randomized study, a microencapsulated bitter ingredient of the root extract consumed by twenty healthy subjects at breakfast on two different occasions, significantly reduced energy intake over the postlunch period, and showed a trend for a higher response of glucagon-like peptide-1, but no significant difference from placebo on appetite. Administration of gentian flavored water to healthy individuals increased peripheral vascular resistance and decreased cardiac output, primarily by reducing stroke volume.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Tayyab M: Personal Communication.
References
Aberham A, Schwaiger S, Stuppner H, Ganzera M. Quantitative analysis of iridoids, secoiridoids, xanthones and xanthone glycosides in Gentiana lutea L. roots by RP-HPLC and LC-MS. J Pharm Biomed Anal. 2007;45:437–42.
Akileshwari C, Muthenna P, Nastasijević B, et al. Inhibition of aldose reductase by Gentiana lutea extracts. Exp Diabetes Res. 2012;2012:147965.
Amin A. Ketoconazole-induced testicular damage in rats reduced by Gentiana extract. Exp Toxicol Pathol. 2008;59:377–84.
Bakuridze AD, Nikolaev SM, Tsagarenshvili NT, et al. Influence of Gentiana lutea L. extract on blood coagulation. Georgian Med News. 2009;172–173:89–91 (Article in Russian).
Balijagić J, Janković T, Zdunić G, et al. Chemical profile, radical scavenging and cytotoxic activity of yellow gentian leaves (Genitaneae luteaefolium) grown in northern regions of Montenegro. Nat Prod Commun. 2012;7:1487–90.
Bianco A, Ramunno A, Melchioni C. Iridoids from seeds of Gentiana lutea. Nat Prod Res. 2003;17:221–4.
Calliste CA, Trouillas P, Allais DP, et al. Free radical scavenging activities measured by electron spin resonance spectroscopy and B16 cell antiproliferative behaviors of seven plants. J Agric Food Chem. 2001;49:3321–7.
Chen L, Liu JC, Zhang XN, et al. Downregulation of NR2B receptors partially contributes to analgesic effects of Gentiopicroside in persistent inflammatory pain. Neuropharmacology. 2008;54:1175–81.
Citová I, Ganzera M, Stuppner H, Solich P. Determination of gentisin, isogentisin, and amarogentin in Gentiana lutea L. by capillary electrophoresis. J Sep Sci. 2008;31:195–200.
Haraguchi H, Tanaka Y, Kabbash A, et al. Monoamine oxidase inhibitors from Gentiana lutea. Phytochemistry. 2004;65:2255–60.
Kakuda R, Machida K, Yaoita Y, et al. Studies on the constituents of Gentiana species. II. A new triterpenoid, and (S)-(+)- and (R)-(−)-gentiolactones from Gentiana lutea. Chem Pharm Bull (Tokyo). 2003;51:885–7.
Kesavan R, Potunuru UR, Nastasijević B, et al. Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts. PLoS One. 2013;8:e61393.
Kesavan R, Chandel S, Upadhyay S, et al. Gentiana lutea exerts anti-atherosclerotic effects by preventing endothelial inflammation and smooth muscle cell migration. Nutr Metab Cardiovasc Dis. 2016;26:293–301.
Kusar A, Zupancic A, Sentjurc M, Baricevic D. Free radical scavenging activities of yellow gentian (Gentiana lutea L.) measured by electron spin resonance. Hum Exp Toxicol. 2006;25:599–604.
Liu SB, Zhao R, Li XS, et al. Attenuation of reserpine-induced pain/depression dyad by gentiopicroside through downregulation of GluN2B receptors in the amygdala of mice. Neuromolecular Med. 2014;16:350–9.
Liu SB, Ma L, Guo HJ, et al. Gentiopicroside attenuates morphine rewarding effect through downregulation of GluN2B receptors in nucleus accumbens. CNS Neurosci Ther. 2012;18:652–8.
Mahady GB, Pendland SL, Stoia A, et al. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res. 2005;19:988–91.
McMullen MK, Whitehouse JM, Whitton PA, Towell A. Bitter tastants alter gastric-phase postprandial haemodynamics. J Ethnopharmacol. 2014;154:719–27.
Menković N, Savikin-Fodulović K, Savin K. Chemical composition and seasonal variations in the amount of secondary compounds in Gentiana lutea leaves and flowers. Planta Med. 2000;66:178–80.
Menkovic N, Juranic Z, Stanojkovic T, et al. Radioprotective activity of Gentiana lutea extract and mangiferin. Phytother Res. 2010;24:1693–6.
Mennella I, Fogliano V, Ferracane R, et al. Microencapsulated bitter compounds (from Gentiana lutea) reduce daily energy intakes in humans. Br J Nutr. 2016;1–10.
Nastasijević B, Lazarević-Pašti T, Dimitrijević-Branković S, et al. Inhibition of myeloperoxidase and antioxidative activity of Gentiana lutea extracts. J Pharm Biomed Anal. 2012;66:191–6.
Olivier DK, van Wyk BE. Bitterness values for traditional tonic plants of southern Africa. J Ethnopharmacol. 2013;147:676–9.
Oztürk N, Başer KH, Aydin S, et al. Effects of Gentiana lutea ssp. symphyandra on the central nervous system in mice. Phytother Res. 2002;16:627–31.
Oztürk N, Korkmaz S, Oztürk Y, Başer KH. Effects of gentiopicroside, sweroside and swertiamarine, secoiridoids from gentian (Gentiana lutea ssp. symphyandra), on cultured chicken embryonic fibroblasts. Planta Med. 2006;72:289–94.
Oztürk N, Herekman-Demir T, Oztürk Y, et al. Choleretic activity of Gentiana lutea ssp. symphyandra in rats. Phytomedicine. 1998;5:283–8.
Savikin K, Menković N, Zdunić G et al. Antimicrobial activity of Gentiana lutea L. extracts. Z Naturforsch C. 2009;64:339–42.
Schmieder A, Schwaiger S, Csordas A, et al. Isogentisin—a novel compound for the prevention of smoking-caused endothelial injury. Atherosclerosis. 2007;194:317–25.
Toriumi Y, Kakuda R, Kikuchi M, et al. New triterpenoids from Gentiana lutea. Chem Pharm Bull (Tokyo). 2003;51:89–91.
Waltenberger B, Liu R, Atanasov AG, et al. Nonprenylated xanthones from Gentiana lutea, Frasera caroliniensis, and Centaurium erythraea as novel inhibitors of vascular smooth muscle cell proliferation. Molecules. 2015;20:20381–90.
Wölfle U, Haarhaus B, Seiwerth J, et al. The herbal bitter drug Gentiana lutea modulates lipid synthesis in human keratinocytes in vitro and in vivo. Int J Mol Sci. 2017;18, pii: E1814.
Yen TL, Lu WJ, Lien LM, et al. Amarogentin, a secoiridoid glycoside, abrogates platelet activation through PLC γ 2-PKC and MAPK pathways. Biomed Res Int. 2014;2014:728019.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Akbar, S. (2020). Gentiana lutea L. (Gentianaceae). In: Handbook of 200 Medicinal Plants. Springer, Cham. https://doi.org/10.1007/978-3-030-16807-0_102
Download citation
DOI: https://doi.org/10.1007/978-3-030-16807-0_102
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16806-3
Online ISBN: 978-3-030-16807-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)